Should You Buy Teleflex Incorporated Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Teleflex Incorporated (TFX) occupies a solid middle-ground position with a Quality of Company score of 6.2/10. At the current market price of $129.02, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 1 of 11 CirclFi valuation models project upside for Teleflex Incorporated (TFX) at $129.02 — the model consensus leans bearish, with a Quality Score of 6.2/10 and Value-Trap risk of 29/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Teleflex Incorporated (TFX) in 2026?
What Is the Bull Case vs the Bear Case for Teleflex Incorporated (TFX)?
| Bull case — $365.45 target (+183.2%) | Bear case — $4.49 target (-96.5%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $365.45 (+183.2%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $4.49 (-96.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +279.8% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
How Does TFX Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: BLCO · RVP · BAX · MLSS · KRMD · POCI · DXR · COO · ICUI · ISRG · RMD
Which Other Stocks Score Like TFX on Quality?
Closest companies to TFX’s Quality of Company score of 6.2/10, across all industries.
- TXMD — TherapeuticsMD, Inc. (QOC 6.2) · analysis
- BHST — BioHarvest Sciences Inc. Common Stock (QOC 6.2) · analysis
- CDXS — Codexis, Inc. (QOC 6.2) · analysis
- WVVI — Willamette Valley Vineyards, Inc. (QOC 6.2) · analysis
- GSIT — GSI Technology, Inc. (QOC 6.2) · analysis
- FUFU — BitFuFu Inc. (QOC 6.2) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does TFX Appear In?
So Is Teleflex Incorporated (TFX) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Teleflex Incorporated at $129.02. 10/11 models flag overvaluation, median fair value sits at $57.52 (-55.4%), and the risk-reward profile appears unfavorable. Quality at 6.2/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Teleflex Incorporated's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About TFX Stock?
Should I buy TFX stock right now?
Based on CirclFi's multi-model analysis, 1 of 11 models see upside for TFX at $129.02. The models are divided, which means the investment case depends heavily on your assumptions about Teleflex Incorporated's future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Teleflex Incorporated?
Key risks include: wide model disagreement (8041% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does TFX compare to its competitors?
Among Medical Instruments & Supplies peers, TFX holds a Quality Score of 6.2/10. Comparable companies include BLCO (QOC 6.3), RVP (QOC 6.2), BAX (QOC 6.3). The relative ranking helps investors identify whether TFX offers better fundamental quality than alternatives in the same sector.
Is TFX a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. TFX's Quality Score of 6.2/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy TFX at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $4.49 to $365.45. At $129.02, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for TFX.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad